Literature DB >> 16533146

Drug therapy of trigeminal neuralgia.

Sergio Canavero1, Vincenzo Bonicalzi.   

Abstract

Trigeminal neuralgia is a chronic pain syndrome of still unestablished origin. Its diagnosis depends on clinical grounds. Drug therapy initially helps a great majority of patients. The choice of drugs is quite large, but truly effective compounds with a tolerable side effect profile remain few. Carbamazepine (or oxcarbazepine) and lamotrigine appear to be the most effective, followed by baclofen. Several patients require further nonpharmacological treatment for which no evidence-based recommendation is possible. In the future, neuromodulation may be brought to bear, as in other chronic pain syndromes.

Entities:  

Mesh:

Year:  2006        PMID: 16533146     DOI: 10.1586/14737175.6.3.429

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  7 in total

Review 1.  Trigeminal neuralgia and its management.

Authors:  Luke Bennetto; Nikunj K Patel; Geraint Fuller
Journal:  BMJ       Date:  2007-01-27

Review 2.  Cranial neuralgias: from physiopathology to pharmacological treatment.

Authors:  Roberto De Simone; Angelo Ranieri; Leonilda Bilo; Chiara Fiorillo; Vincenzo Bonavita
Journal:  Neurol Sci       Date:  2008-05       Impact factor: 3.307

3.  Motor cortex stimulation for facial chronic neuropathic pain: A review of the literature.

Authors:  Guillermo A Monsalve
Journal:  Surg Neurol Int       Date:  2012-10-31

4.  Trigeminal neuralgia.

Authors:  William P Cheshire
Journal:  Curr Pain Headache Rep       Date:  2007-02

5.  Effectiveness of the association between carbamazepine and peripheral analgesic block with ropivacaine for the treatment of trigeminal neuralgia.

Authors:  Laurinda Lemos; Ramalho Fontes; Sara Flores; Pedro Oliveira; Armando Almeida
Journal:  J Pain Res       Date:  2010-10-25       Impact factor: 3.133

6.  Pharmacological versus microvascular decompression approaches for the treatment of trigeminal neuralgia: clinical outcomes and direct costs.

Authors:  Laurinda Lemos; Carlos Alegria; Joana Oliveira; Ana Machado; Pedro Oliveira; Armando Almeida
Journal:  J Pain Res       Date:  2011-08-24       Impact factor: 3.133

Review 7.  Therapeutic efficacy and safety of botulinum toxin type A in trigeminal neuralgia: a systematic review.

Authors:  Yong Hu; Xiaofei Guan; Lin Fan; Mu Li; Yiteng Liao; Zhiyu Nie; Lingjing Jin
Journal:  J Headache Pain       Date:  2013-08-21       Impact factor: 7.277

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.